CP
EOLS icon

CenterBook Partners’s Evolus EOLS Stock Holding History

CenterBook Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Buy
+91,741
New +$542K 0.03% 469

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

CenterBook Partners's EOLS Position: Q2 2026 in Review

CenterBook Partners opened a new position in Evolus (EOLS) in Q2 2026: 91,741 shares worth $637K. The stake represents 0.03% of the portfolio and ranks #469 among its holdings.

158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • CenterBook Partners held 91,741 shares of Evolus worth $637K as of Q2 2026.
  • Evolus was a new CenterBook Partners position in Q2 2026.
  • Evolus made up 0.03% of CenterBook Partners's portfolio in Q2 2026, its #469 holding.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.